Furthermore, Hashiba et al. reported that HO-1 gene transfer is a potential strategy to treat lung injury caused by IAV [132] and Cummins et al. suggested that the therapeutic induction of HO-1 expression may represent a novel adjuvant to enhance influenza vaccine effectiveness [133]. The gene discussed is HMOX1; the disease is influenza.